当前位置:主页 > 医学论文 > 消化疾病论文 >

钆塞酸二钠增强MRI在预测肝癌和肝硬化病理分级及评估肝功能中的应用

发布时间:2018-05-23 13:03

  本文选题:钆塞酸二钠 + 磁共振 ; 参考:《南方医科大学》2017年博士论文


【摘要】:肝纤维化和肝硬化在我国的发病率非常高,随着病情的进展,肝纤维化可以向肝硬化发展,最终演变为肝细胞肝癌(hepatocellular carcinoma HCC)。目前对肝纤维化和肝硬化的评估主要依靠肝穿刺组织的病理检查,HCC病理结果需依靠术后检查,肝穿刺有一定的缺点。因此需寻找一种无损伤的检查方法来预测肝纤维化、肝硬化和HCC的病理学分级,并且能精确评估肝功能的情况。因此本实验进行了以下方面的研究:(1)分析Gd-EOB-DTPA增强MRI预测HCC的病理学分级;(2)分析大鼠Gd-EOB-DTPA增强MRI预测肝硬化的病理学分级;(3)分析Gd-EOB-DTPA增强MRI与不同病变程度肝脏的病理学相关性;(4)Gd-EOB-DTPA 增强 MRI 在评估功能性肝体积(functional liver volume,FLV)与肝功能Child-Pugh分级相关性中的作用。方法:1.分析Gd-EOB-DTPA增强MRI癌灶信号绝对增强强度(absolute enhancement value,AEV)和对比增强率(contrast enhancement ratio,CER),及癌灶对肝脏的对比增强率(CERtl,CERtumor to liver)与病理分级的相关性。2.分析大鼠肝脏Gd-EOB-DTPA增强MRI的AEV和CER。根据Laennec分级系统对肝硬化进行分级。分析AEV和CER与肝硬化病理分级的相关性。3.定量分析Gd-EOB-DTPA增强MRI癌灶周围肝脏的AEV和CER。分析AEV和CER与不同病变程度肝脏病理分级的相关性。4.计算肝段的CER和解剖性肝体积(anatomical liver volume,ALV)。利用Ⅰvol×ⅠCER+Ⅱvol×ⅡCER+……+Ⅷvol×ⅧCER.计算 FLV。分析 ALV 和 FLV 与肝功能Child-Pugh分级的相关性。结果:1.CERtl与肝癌的分化程度有最显著的负相关性。ROC曲线中,CERd在肝癌分化程度Ⅰ和Ⅱ级,Ⅱ和Ⅲ级,Ⅲ和Ⅳ级间的临界值为分别为0.535,0.40,0.295。CERtl与病理分级的一致性检验的kappa值为0.62。2.肝硬化的病理分级和CER之间存在更显著的负相关。肝硬化病理分级之间的差异性通过ROC曲线下面积来分析。轻和中度肝硬化,中和重度肝硬化之间的CER临界值分别为0.535和0.335。CER和病理分级之间的一致性检验,kappa 值为 0.73。3.不同病变肝脏的病理分级与CER有最显著的负相关性。通过ROC曲线的分析,正常肝脏和肝纤维化,肝纤维化和肝硬化间的CER临界值分别为0.76和0.46。分析CER和不同病变程度肝脏病理分级之间的一致性检验,kappa值为0.41。在轻和中度肝硬化组,中和重度肝硬化之间CER临界值分别为0.425和0.325。分析CER和肝硬化病理分级之间的一致性检验,kappa值为0.60。4.肝功能Child-Pugh分级与ALV的相关性(r =-0.792,p0.001);肝功能Child-Pugh 分级与 FLV 的相关性(r=-0.911,p0.001)。FLV 与肝功能 Child-Pugh分级有更显著的负相关性。结论:1.CERtl与HCC的分化程度之间有比较显著的相关性。分析Gd-EOB-DTPA增强MRI可以预测病理分级。2.CER与肝硬化的病理分级存在比较显著的相关性,CER在区别不同病变程度肝脏病理学分级的能力较差,但可以预测肝硬化的病理分级。3.结合CER和ALV计算肝脏的FLV实现区域性肝功能的整合,较ALV能更好的反映肝脏的功能。项目创新性:1.定量分析Gd-EOB-DTPA增强MRI,创新性的使用公式CER=SIth-SItu/SIlh-SIlu 预测 HCC 的病理学分级。2.创新性的利用定量分析钆塞酸二钠增强MRI,并通过计算CER预测肝硬化的病理学分级。3.创新性的结合Gd-EOB-DTPA增强MRI和ALV计算肝脏的FLV,并实现区域性肝功能的计算和整合。
[Abstract]:The incidence of liver fibrosis and cirrhosis in our country is very high. With the progress of the disease, liver fibrosis can develop to liver cirrhosis and eventually become liver cell liver cancer (hepatocellular carcinoma HCC). The evaluation of liver fibrosis and liver cirrhosis depends mainly on the pathological examination of liver puncture tissue, and the pathological results of HCC need to be checked by postoperative examination, Liver puncture has some shortcomings. Therefore, it is necessary to find a noninvasive method to predict the pathological grading of liver fibrosis, liver cirrhosis and HCC, and to evaluate the liver function accurately. Therefore, the following studies have been carried out in this experiment: (1) analysis of the pathological grade of Gd-EOB-DTPA enhanced MRI prediction of HCC; (2) analysis of Gd-EOB-DTPA in rat The histopathological classification of liver cirrhosis was predicted by enhanced MRI; (3) the pathological correlation between Gd-EOB-DTPA enhanced MRI and the liver of different pathological changes was analyzed; (4) the role of Gd-EOB-DTPA enhanced MRI in evaluating the correlation between functional hepatic volume (functional liver volume, FLV) and liver function Child-Pugh classification. Method: 1. analysis Gd-EOB-DTPA enhanced MRI cancer Absolute enhancement value (AEV) and contrast enhancement (contrast enhancement ratio, CER), and the correlation of the contrast enhancement of the liver (CERtl, CERtumor to liver) and pathological grading. Analysis of the correlation between AEV and CER and the pathological classification of liver cirrhosis by.3. quantitative analysis of the AEV and CER. analysis of the liver surrounding the MRI carcinoma and the correlation between AEV and CER and the pathological grade of liver with different pathological changes;.4. for the CER and anatomical liver volume of the liver segment. The correlation between ALV and FLV and liver function Child-Pugh classification was calculated by FLV.. Results: the degree of differentiation between 1.CERtl and liver cancer was the most significant negative correlation.ROC curve. CERd was in the degree of differentiation of liver cancer I and II, grade II and grade III, and the critical value between grade III and grade IV was the consistency of 0.535,0.40,0.295.CERtl and pathological grading, respectively. The kappa value of the test was a more significant negative correlation between the pathological grades of 0.62.2. cirrhosis and CER. The difference between the pathological grades of liver cirrhosis was analyzed under the ROC curve. The critical value of CER between mild and moderate cirrhosis, and severe cirrhosis was 0.535 and 0.335.CER, and the consistency test between pathological grades, kappa The pathological grading of the liver of 0.73.3. with different lesions was the most significant negative correlation with CER. Through the analysis of the ROC curve, the critical values of normal liver and liver fibrosis, liver fibrosis and liver cirrhosis were 0.76 and 0.46., respectively, and the consistency test between CER and the pathological grade of different pathological changes, the kappa value was 0.41. in light and middle. The critical value of CER between the liver cirrhosis and the severe cirrhosis was 0.425 and 0.325., respectively, for the consistency test between CER and the pathological grading of liver cirrhosis. The kappa value was the correlation between the 0.60.4. liver function Child-Pugh grading and ALV (R =-0.792, p0.001); the correlation between the liver function Child-Pugh classification and FLV, and the liver function Ild-Pugh classification has a more significant negative correlation. Conclusion: there is a significant correlation between the differentiation degree of 1.CERtl and HCC. The analysis of Gd-EOB-DTPA enhanced MRI can predict a significant correlation between pathological grade.2.CER and the pathological grading of liver cirrhosis, and CER is less capable of differentiating the pathological grade of liver from different pathological changes, but it can be less effective. To predict the pathological grade.3. of liver cirrhosis combined with CER and ALV to calculate the integration of liver function in the liver, which can better reflect the liver function than ALV. Project innovation: 1. quantitative analysis of Gd-EOB-DTPA enhanced MRI, innovative use formula CER=SIth-SItu/SIlh-SIlu to predict the innovative utilization of HCC's pathological grade.2.. The MRI was enhanced by the analysis of two sodium gadolinium acid, and the pathological grading of liver cirrhosis was calculated by CER to predict the MRI and ALV to calculate the FLV of the liver, and to realize the calculation and integration of the regional liver function.
【学位授予单位】:南方医科大学
【学位级别】:博士
【学位授予年份】:2017
【分类号】:R735.7;R575.2

【相似文献】

相关期刊论文 前10条

1 金腊梅;吴建伟;瞿献莉;高红;张艳;卢光明;;磁共振钆塞酸二钠增强评价肝脏功能可行性研究[J];中国临床医学影像杂志;2013年09期

2 田野;郭丽丽;付旷;;钆塞酸二钠增强磁共振成像在肝脏局灶性病变中的诊断应用[J];临床荟萃;2014年04期

3 李伟;;呼吸运动伪影影响钆塞酸二钠肝动脉期成像:使用多动脉期采集检查恢复[J];国际医学放射学杂志;2014年04期

4 T.A.Hope;A.Doherty;R.Aslam;A.Qayyum;R.C.Brasch;龙柳;;活动性肝纤维化大鼠模型中注射钆塞酸二钠后的钆沉积及肝纤维化[J];国际医学放射学杂志;2012年05期

5 A.Yamada;T.Hara;Y.Fujinaga;K.Ueda;M.Kadoya;杨栋;;钆塞酸二钠增强MRI对肝功能的定量评估[J];国际医学放射学杂志;2011年06期

6 张静;潘晶晶;叶慧义;;肝胆特异性对比剂钆塞酸二钠对肝、脾、肾ADC值的影响[J];中国医学影像学杂志;2014年07期

7 M.S. Davenport;B.L. Viglianti;M.M. Al-Hawary;E.M. Caoili;R.K. Kaza;P.S.C. Liu;孙珊珊;;比较钆塞酸二钠与钆贝葡胺静脉注射后的急性短暂性呼吸困难:对动脉期影像质量的影响[J];国际医学放射学杂志;2013年02期

8 徐莉莉;盛复庚;陆虹;乔鹏岗;周娟;张洪涛;邢旭东;李功杰;;钆塞酸二钠在肝脏FNH诊断中的临床价值[J];医学影像学杂志;2013年05期

9 金腊梅;吴建伟;瞿献莉;高红;张艳;卢光明;;钆塞酸二钠在肝硬化病人胆道成像中的应用价值[J];中国临床医学影像杂志;2013年10期

10 钟武宁;康巍;胡雪莹;王曼;苏丹柯;赖少侣;;钆塞酸二钠增强MRI对小肝癌诊断效果的meta分析[J];中国CT和MRI杂志;2014年06期

相关重要报纸文章 前1条

1 陆志城;钆塞酸二钠针[N];医药经济报;2009年

相关博士学位论文 前2条

1 童洪飞;钆塞酸二钠增强MRI在预测肝癌和肝硬化病理分级及评估肝功能中的应用[D];南方医科大学;2017年

2 叶枫;钆塞酸二钠增强MRI在慢性肝病背景下肝癌的应用研究[D];北京协和医学院;2015年

相关硕士学位论文 前6条

1 王莉莉;钆塞酸二钠特异性增强磁共振成像扫描评估肝脏功能的研究[D];兰州大学;2015年

2 谢双双;钆塞酸二钠增强磁共振成像在肝功能评估中的应用[D];天津医科大学;2015年

3 杨林林;比较钆塞酸二钠和钆喷酸葡胺增强的MRI检查在结直肠癌肝转移的诊断价值[D];吉林大学;2016年

4 王艾博;肝脏动脉期一过性强化灶及小肝癌在钆塞酸二钠与钆喷葡胺增强磁共振的比较研究[D];大连医科大学;2016年

5 金腊梅;磁共振钆塞酸二钠增强评价肝脏功能的可行性研究及在肝硬化病人胆道成像中的应用价值[D];安徽医科大学;2014年

6 肖煜东;钆塞酸二钠增强磁共振对肝癌TACE术后局部肝功能损伤的评价[D];中南大学;2014年



本文编号:1924851

资料下载
论文发表

本文链接:https://www.wllwen.com/yixuelunwen/xiaohjib/1924851.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户6fec2***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com